{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Tariquidar",
  "nciThesaurus": {
    "casRegistry": "206873-63-4",
    "chebiId": "",
    "chemicalFormula": "C38H38N4O6",
    "definition": "An anthranilamide derivative with multidrug resistance properties.  Tariquidar non-competitively binds to the p-glycoprotein transporter, thereby inhibiting transmembrane transport of anticancer drugs.  Inhibition of transmembrane transport may result in increased intracellular concentrations of an anticancer drug, thereby augmenting its cytotoxicity.",
    "fdaUniiCode": "J58862DTVD",
    "identifier": "C2246",
    "preferredName": "Tariquidar",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C1744"
    ],
    "synonyms": [
      "TARIQUIDAR",
      "Tariquidar",
      "XR9576",
      "tariquidar"
    ]
  }
}